. Author manuscript; available in PMC: 2013 Jul 9.

Published in final edited form as: Breast Cancer Res Treat. 2012 Mar 29;134(3):1041–1055. doi: 10.1007/s10549-012-1992-x

Table 2. Cell Cycle Analysis of cell lines treated with SL analogues.

Cell Line	SL (dose/ppm)	SubG1/poptosis	Cell Cycle Distribution (%)

			G1	S	G2

BJ fibroblast	Vehicle	0.21	84.25	2.510	10.17
	EGO5 (10)	0.49	82.29	4.480	10.50
	ST362 (5)	0.72	83.42	1.580	12.86
	MEB55 (5)	0.57	78.96	5.930	11.54

MDA-MB-231	Vehicle	0.41	60.43	13.02	24.08
	EGO5 (10)	11.32	34.74	14.59	35.70
	ST362 (5)	4.17	42.17	11.90	37.93
	MEB55 (5)	3.88	49.61	14.51	28.33